Affymetrix, UniGene, Baylor College of Medicine, Flybase, Berkeley Drosophila Genome Project

Mar 24, 2004

Premium

Affymetrix launched two new catalog GeneChip microarrays. The company this week rolled out the GeneChip Rat Genome 230 2.0 array and last week announced the Drosophila Genome 2.0 array.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Model of Discovery

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

Subcommittee Calls for More Funding

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Limit of Relevance

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

This Week in PLOS

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

Optimized NGS Library Preparation with Acoustic Liquid Handling

Jun

06

Featured Webinar

Accelerating Crop Research with High-Quality Affordable Genome Assemblies

This webinar will discuss the impact of affordable de novo genome assemblies on crop research.

Jun

18

Featured Webinar

Clinical Genomics of NTRK Fusion Detection in Cancer

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.

Menu